Abviris and Mayo Clinic sign cooperation for research into HPV induced cancer diagnostics

Rochester, MN (USA) / Ahrensburg, Germany: Mayo Clinic and Abviris Deutschland GmbH have successfully signed a cooperation agreement for preclinical research into the diagnostics of HPV induced cancer.

Mayo Clinic is one of the leading healthcare and medical research centers of the world.

HPV and cancer

HPV is responsible for 5% of all cancers, men and women are equally affected. Head and neck cancers in men, induced by HPV, have surpassed cervical cancer incidences in women in many countries.

Abviris is dedicated to improving the clinical outcomes of patients and enable clinicians worldwide to fight HPV-induced tumors, including head and neck cancer, penile and anal tumors, vaginal and vulvar cancer and of course cervical cancer.